Growth Opportunity Strong focus on wound healing technologies and non-invasive UltraMIST systems positions SANUWAVE to expand into hospitals, clinics, and long-term care facilities seeking faster, pain-free wound care solutions that can reduce amputations and complications.

Recurring Revenue Evidence of growing consumables usage alongside device sales suggests a pipeline for consumables and service contracts, offering a steady recurring revenue stream through extended product use and maintenance.

Ecosystem Leverage Adopting a tech stack that includes CRM/marketing automation and analytics tools indicates readiness for targeted outbound campaigns, cross-sell opportunities with adjacent wound care products, and data-driven account targeting.

Performance Signals Q2 2026 results show revenue normalization with slight declines in equipment sales but resilience in overall demand, signaling opportunities to upsell newer UltraMIST iterations to existing customers amid market adjustments.

Strategic Partnerships Mid-market positioning with peers in wound care (e.g., Misonix, Organogenesis) suggests potential channel partnerships or co-marketing arrangements to expand geographic reach and hospital network penetration.